Codexis CDXS
NASDAQ CDXS
$1.63 +0.05 (+3.48%)
As of: Aug 21, 2026 · 1:42 PM EDT

Codexis (CDXS) EBIT Margin (2010 - 2026)

Codexis (CDXS) posted quarterly EBIT Margin of 52.75% for Q1 2026, up 21884.0% year-over-year from N/an in Q1 2025, and down 294.4% quarter-over-quarter from 27.13% in Q4 2025.

Codexis (CDXS) EBIT Margin (2010 - 2026) Analysis & Trends

Codexis' EBIT Margin history runs 17 years deep, the most recent figure standing at 52.75% for Q1 2026.

  • In Q1 2026, EBIT Margin rose 21884.0% year-over-year to 52.75%; the TTM figure through Mar 2026 stood at 37.51% (up 9722.0% YoY), while the FY2025 annual figure was 59.3%, up 3931.0% from the prior year.
  • EBIT Margin for Q1 2026 stood at 52.75%, down from 27.13% in the prior quarter.
  • The five-year high for EBIT Margin was 27.13% in Q4 2025, with the low at 345.59% in Q3 2023.
  • The 5-year median for EBIT Margin is 69.63% (2024), against an average of 118.96%.
  • The sharpest annual moves came in 2023 and 2026: EBIT Margin plunged 31473 bps in 2023, then surged 21884 bps in 2026.
  • Codexis' EBIT Margin stood at 66.92% in 2022, then jumped by 108 bps to 5.62% in 2023, then sank by 709 bps to 34.21% in 2024, then surged by 179 bps to 27.13% in 2025, then plunged by 294 bps to 52.75% in 2026.
  • Business Quant data shows CDXS's EBIT Margin at 52.75% in Q1 2026, 27.13% in Q4 2025, and 220.31% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Vertex Pharmaceuticals 139.25 Bn 131.40 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 30.15%
3 Argenx Se 65.43 Bn 60.25 Bn 1.37 Bn 32.54%
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn -562.07%
5 BeOne Medicines 42.10 Bn 37.00 Bn 1.53 Bn 19.06%
6 Alnylam Pharmaceuticals 31.61 Bn 28.31 Bn 992.69 Mn 17.93%
7 BioNTech SE 28.03 Bn 9.63 Bn 668.28 Mn -35.57%
8 Insmed 27.49 Bn 26.33 Bn 358.27 Mn -0.36%
9 Royalty Pharma 27.33 Bn 26.49 Bn - 19.75%
10 Codexis 148.42 Mn 93.50 Mn 11.40 Mn -75.29%

Historic Data

Download Data
DateValue
Jun 30, 2026 -75.29%
Mar 31, 2026 -52.75%
Dec 31, 2025 27.13%
Sep 30, 2025 -220.31%
Jun 30, 2025 -83.91%
Mar 31, 2025 -271.59%
Dec 31, 2024 -34.21%
Sep 30, 2024 -129.02%
Jun 30, 2024 -284.90%
Mar 31, 2024 -69.63%
Dec 31, 2023 5.62%
Sep 30, 2023 -345.59%
Jun 30, 2023 -252.52%
Mar 31, 2023 -182.29%
Dec 31, 2022 -66.92%
Sep 30, 2022 -30.86%
Jun 30, 2022 -6.79%
Mar 31, 2022 -23.73%
Dec 31, 2021 -42.39%
Sep 30, 2021 3.62%